Resection Versus Transplant for Hepatocellular Carcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 203
Special Issue Editor
Interests: hepatocellular carcinoma; liver resection; liver transplantation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Liver transplantation (LT) is, theoretically, the ideal treatment modality to prevent recurrence in patients with hepatocellular carcinoma (HCC). However, recurrence occurs even after LT, with poor patient prognosis. To avoid recurrence, several selection criteria have been reported for LT. Among these, the Milan criteria is the most well-known, first reported in 1996, later followed by many others with good survival outcomes.
Liver resection (LR) is another curative treatment for patients with HCC. While recurrence also occurs after LR, repeat LR provides a good prognosis. Considering the above, the appropriate treatment modality for patients with HCC is not well-determined.
This Special Issue aims to compare the treatment outcomes following LT and LR, welcoming original research articles and reviews on this topic.
Dr. Takashi Kokudo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver resection
- hepatocellular carcinoma
- liver transplantation
- vascular invasion
- Milan criteria
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
